Search

Nukacin ISK-1 in active state
Authors
Kohda, D., Fujinami, D.
Assembly
Lantibiotic nukacin
Entity
1. Lantibiotic nukacin (polymer, Thiol state: all other bound), 27 monomers, 2965.493 Da Detail

KKKSGVIPXV XHDCHMNXFQ FVFXCCS


Formula weight
2965.493 Da
Entity Connection
thioether 3 Detail

IDTypeValue orderAtom ID 1Atom ID 2
1thioethersing1:DBB9:CB1:CYS14:SG
2thioethersing1:DAL11:CB1:CYS25:SG
3thioethersing1:DAL18:CB1:CYS26:SG

Source organism
Staphylococcus warneri
Exptl. method
solution NMR
Refine. method
simulated annealing
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 85.2 %, Completeness: 96.6 %, Completeness (bb): 97.8 % Detail

Polymer type: polypeptide(L)

Total1H
All96.6 % (141 of 146)96.6 % (141 of 146)
Backbone97.8 % (45 of 46)97.8 % (45 of 46)
Sidechain96.0 % (96 of 100)96.0 % (96 of 100)
Aromatic100.0 % (19 of 19)100.0 % (19 of 19)
Methyl100.0 % (8 of 8)100.0 % (8 of 8)

1. Lantibiotic nukacin

KKKSGVIPXV XHDCHMNXFQ FVFXCCS

Sample

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 328 K, pH 3.5, Details 13 mM nukacin ISK-1, 34 mM [U-2H] dodecylphosphocholine, 10 mM glycine, 90% H2O/10% D2O


#NameIsotope labelingTypeConcentration
1dodecylphosphocholine[U-2H]34 mM
2glycinenatural abundance10 mM
3nukacin ISK-1natural abundanceprotein13 mM
4H2Onatural abundancesolvent90 %
5D2O[U-2H]solvent10 %

Protein Blocks Logo
Calculated from 20 models in PDB: 5Z5Q, Strand ID: A Detail


Release date
2019-01-26
Citation
The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
Fujinami, D., Mahin, A.A., Elsayed, K.M., Islam, M.R., Nagao, J.I., Roy, U., Momin, S., Zendo, T., Kohda, D., Sonomoto, K.
Commun. Biol. (2018), 1, 150-150, PubMed 30272026 , DOI 10.1038/s42003-018-0150-3 ,
Related entities 1. Lantibiotic nukacin, : 1 : 1 : 1 : 7 entities Detail
Experiments performed 2 experiments Detail
Chemical shift validation 3 contents Detail
Keywords ANTIBIOTIC, lantibiotics